About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials in Florida | 514 Studies

Clinical Trials Ovarian CancerFlorida

Ovarian Cancer Clinical Trials in Florida

Find 514 clinical trials for ovarian cancer near Florida. Connect with research centers in your area.

All Ovarian Cancer trials nationwide All trials in Florida

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 141-160 of 514 trials

UnknownDNA Single Nucleotide Polymorphisms as Predictors of ToxicityThe presence of single nucleotide polymorphisms (SNPs) in genes involved in platinum and taxane metabolism and detoxification have been correlated to increased risk of severe…NCT02478476·Orlando, Florida RecruitingStudy Evaluating Safety, Tolerability, and Metabolism of NiraparibThe purpose of this study is to identify the genetic characteristic(s), specifically degree of African ancestry, and environmental characteristic(s) that appear to be related to…NCT06412120·Fort Lauderdale, Florida and 3 others UnknownWeekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and PlatinumRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003160·Mobile, Alabama and 17 others

Ovarian Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedNiraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian CancerThis Phase 1/2 study will evaluate the safety and efficacy of combination treatment with niraparib and pembrolizumab (MK-3475) in patients with advanced or metastatic…NCT02657889·Birmingham, Alabama and 29 others

TerminatedOral AMXT 1501 Dicaprate in Combination With IV DFMOA Phase 1B/2A study will be conducted to establish safety and dose level of AMXT 1501 dicaprate in combination with IV DFMO, in cancer patients.NCT05500508·Phoenix, Arizona and 6 others

CompletedPaclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian CancerThis trial will compare the efficacy and toxicity of standard first-line chemotherapy alone vs. standard chemotherapy plus sorafenib in patients with stage III/IV ovarian cancer…NCT00390611·Jonesboro, Arkansas and 16 others

TerminatedFOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian CancerThis is a multicenter, multinational, randomized, double-blind, 2-arm, parallel-group, Phase 2/3 study to evaluate the efficacy and safety of PCC plus bevacizumab and CA4P versus…NCT02641639·Birmingham, Alabama and 39 others

Active not recruitingTesting the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced CancerThis phase I trial studies the side effects and best dose of ziv-aflibercept when given together with pembrolizumab in treating patients with solid tumors that that may have…NCT02298959·Tampa, Florida and 8 others

TerminatedStudy of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene AmplificationsBBI-355 is an oral, potent, selective checkpoint kinase 1 (or CHK1) small molecule inhibitor in development as an ecDNA (extrachromosomal DNA) directed therapy (ecDTx).NCT05827614·Los Angeles, California and 15 others

CompletedA Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and NeckThe purpose of the study is to estimate the rate of response for patients with ovarian, non-small cell lung, prostate, colorectal, gastroesophageal, and head and neck cancers who…NCT01059643·Jonesboro, Arkansas and 17 others

CompletedTRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube CancerThe purpose of this study is to determine if treatment with paclitaxel plus AMG 386 is superior to paclitaxel plus placebo in women with recurrent partially platinum sensitive or…NCT01204749·Phoenix, Arizona and 224 others

UnknownA Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA MutationsThis is a phase 1, Open-label, multicenter Dose Escalation study of BTP-114, a novel platinum product, in patients with advanced solid tumors and BRCA or other DNA repair mutation.NCT02950064·Sarasota, Florida and 7 others

RecruitingA Study of Sigvotatug Vedotin in Advanced Solid TumorsThis trial will look at a drug called sigvotatug vedotin (SGN-B6A) alone and with pembrolizumab, with or without chemotherapy, to find out whether it is safe for people who have…NCT04389632·Anchorage, Alaska and 157 others

CompletedA Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic CancerThis is a Phase I, multi-center, multiple ascending dose study to evaluate the clinical safety and immune response of IDC-G305 when injected intramuscularly in patients with…NCT02015416·Scottsdale, Arizona and 3 others

CompletedAssess Cancer in Ovarian Tumors With Biomarkers.Purpose The OvaRI assay clinical trial is directed at evaluating a novel proteomics-based blood test.NCT00436189·Hoover, Alabama and 17 others

Active not recruitingTesting the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib AloneThis phase II trial studies the effects of the combination of olaparib and durvalumab, cediranib and durvalumab, olaparib and capivasertib, and cediranib alone in treating…NCT03660826·Birmingham, Alabama and 760 others

Active not recruitingOregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking SurgeryStudy to compare the safety and efficacy of oregovomab versus placebo, administered in combination with specific cycles of a standard six-cycle chemotherapy regimen (paclitaxel…NCT04498117·Phoenix, Arizona and 147 others

RecruitingWith Love, Grandma ("Con Cariño, Abuelita") Pilot StudyThe purpose of this study is to assess the feasibility, acceptability, and preliminary effects of a digital (web and mobile-phone-based) program to improve lifestyle behaviors…NCT05721976·Miami, Florida

CompletedSafety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to ChemotherapyThe purpose of this study is to determine whether the investigational drug catumaxomab delivered in the planned treatment schedule is a safe and effective treatment for women with…NCT00377429·Tucson, Arizona and 11 others

CompletedTrametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity CancerThis phase II/III trial studies how well trametinib works and compares it to standard treatment with either letrozole, tamoxifen, paclitaxel, pegylated liposomal doxorubicin, or…NCT02101788·Huntsville, Alabama and 500 others

PreviousPage 8 of 26Next

Other Conditions in Florida

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia